CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will present at the 2nd Annual Cantor Fitzgerald Healthcare Conference on Tuesday, July 12, 2016 at 4:00 p.m. Eastern Time. The conference is being held at Le Parker Meridien in New York City.
